These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
396 related items for PubMed ID: 27176231
1. Effects of NVP-BEZ235 on the proliferation, migration, apoptosis and autophagy in HT-29 human colorectal adenocarcinoma cells. Yu Y, Yu X, Ma J, Tong Y, Yao J. Int J Oncol; 2016 Jul; 49(1):285-93. PubMed ID: 27176231 [Abstract] [Full Text] [Related]
2. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines. Xin P, Li C, Zheng Y, Peng Q, Xiao H, Huang Y, Zhu X. Drug Des Devel Ther; 2017 Jul; 11():1115-1126. PubMed ID: 28435223 [Abstract] [Full Text] [Related]
3. Effects of endoplasmic reticulum stress on the autophagy, apoptosis, and chemotherapy resistance of human breast cancer cells by regulating the PI3K/AKT/mTOR signaling pathway. Zhong JT, Yu J, Wang HJ, Shi Y, Zhao TS, He BX, Qiao B, Feng ZW. Tumour Biol; 2017 May; 39(5):1010428317697562. PubMed ID: 28459209 [Abstract] [Full Text] [Related]
4. Co-treatment with BEZ235 enhances chemosensitivity of A549/DDP cells to cisplatin via inhibition of PI3K/Akt/mTOR signaling and downregulation of ERCC1 expression. Xia A, Li H, Li R, Lu L, Wu X. Oncol Rep; 2018 Oct; 40(4):2353-2362. PubMed ID: 30066933 [Abstract] [Full Text] [Related]
5. Inhibition of Autophagy Increases Proliferation Inhibition and Apoptosis Induced by the PI3K/mTOR Inhibitor NVP-BEZ235 in Breast Cancer Cells. Ji Y, Di W, Yang Q, Lu Z, Cai W, Wu J. Clin Lab; 2015 Oct; 61(8):1043-51. PubMed ID: 26427150 [Abstract] [Full Text] [Related]
6. Dual PI3K/mTOR inhibitor NVP-BEZ235-induced apoptosis of hepatocellular carcinoma cell lines is enhanced by inhibitors of autophagy. Chang Z, Shi G, Jin J, Guo H, Guo X, Luo F, Song Y, Jia X. Int J Mol Med; 2013 Jun; 31(6):1449-56. PubMed ID: 23588698 [Abstract] [Full Text] [Related]
7. miR-212 and mTOR form a regulation loop to modulate autophagy in colorectal adenoma HT-29 cells. Ji C, Ju S, Qiang J. Discov Med; 2018 Jun; 25(140):265-275. PubMed ID: 30021100 [Abstract] [Full Text] [Related]
8. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells. Li H, Jin X, Zhang Z, Xing Y, Kong X. Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777 [Abstract] [Full Text] [Related]
9. Abrogation of Autophagy by Chloroquine Alone or in Combination with mTOR Inhibitors Induces Apoptosis in Neuroendocrine Tumor Cells. Avniel-Polak S, Leibowitz G, Riahi Y, Glaser B, Gross DJ, Grozinsky-Glasberg S. Neuroendocrinology; 2016 Jul; 103(6):724-37. PubMed ID: 26619207 [Abstract] [Full Text] [Related]
10. Dual inhibitor of phosphoinositide 3-kinase/mammalian target of rapamycin NVP-BEZ235 effectively inhibits cisplatin-resistant urothelial cancer cell growth through autophagic flux. Li JR, Cheng CL, Yang CR, Ou YC, Wu MJ, Ko JL. Toxicol Lett; 2013 Jul 18; 220(3):267-76. PubMed ID: 23651616 [Abstract] [Full Text] [Related]
11. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells. Yu Z, Xie G, Zhou G, Cheng Y, Zhang G, Yao G, Chen Y, Li Y, Zhao G. Cancer Lett; 2015 Oct 10; 367(1):58-68. PubMed ID: 26188279 [Abstract] [Full Text] [Related]
12. Oridonin enhances the anticancer activity of NVP-BEZ235 against neuroblastoma cells in vitro and in vivo through autophagy. Zhang LD, Liu Z, Liu H, Ran DM, Guo JH, Jiang B, Wu YL, Gao FH. Int J Oncol; 2016 Aug 10; 49(2):657-65. PubMed ID: 27278249 [Abstract] [Full Text] [Related]
13. Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma. Yang F, Qian XJ, Qin W, Deng R, Wu XQ, Qin J, Feng GK, Zhu XF. PLoS One; 2013 Aug 10; 8(3):e59879. PubMed ID: 23533654 [Abstract] [Full Text] [Related]
14. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer]. Chen J, Wang Q, Zhang W, Li L. Zhonghua Fu Chan Ke Za Zhi; 2016 Apr 25; 51(4):285-92. PubMed ID: 27116987 [Abstract] [Full Text] [Related]
15. NVP-BEZ235 Attenuated Cell Proliferation and Migration in the Squamous Cell Carcinoma of Oral Cavities and p70S6K Inhibition Mimics its Effect. Hsu CM, Lin PM, Lin HC, Tsai YT, Tsai MS, Li SH, Wu CY, Yang YH, Lin SF, Yang MY. Int J Mol Sci; 2018 Nov 10; 19(11):. PubMed ID: 30423811 [Abstract] [Full Text] [Related]
16. Endoplasmic reticulum stress could induce autophagy and apoptosis and enhance chemotherapy sensitivity in human esophageal cancer EC9706 cells by mediating PI3K/Akt/mTOR signaling pathway. Zhou F, Li YH, Wang JJ, Pan J, Lu H. Tumour Biol; 2017 Jun 10; 39(6):1010428317705748. PubMed ID: 28631572 [Abstract] [Full Text] [Related]
17. Intravesical dual PI3K/mTOR complex 1/2 inhibitor NVP-BEZ235 therapy in an orthotopic bladder cancer model. Matsushima M, Kikuchi E, Matsumoto K, Hattori S, Takeda T, Kosaka T, Miyajima A, Oya M. Int J Oncol; 2015 Jul 10; 47(1):377-83. PubMed ID: 25963317 [Abstract] [Full Text] [Related]
18. Dual PI3K/mTOR Inhibitor BEZ235 combined with BMS-1166 Promoting Apoptosis in Colorectal Cancer. Liu X, Xu W, Li L, Zhang Z, Lu M, Xia X. Int J Med Sci; 2024 Jul 10; 21(10):1814-1823. PubMed ID: 39113885 [Abstract] [Full Text] [Related]
19. Simultaneous perturbation of the MAPK and the PI3K/mTOR pathways does not lead to increased radiosensitization. Kuger S, Flentje M, Djuzenova CS. Radiat Oncol; 2015 Oct 24; 10():214. PubMed ID: 26498922 [Abstract] [Full Text] [Related]
20. [β-Lapachone combined with NVP-BEZ235 inhibit proliferation and migration of BGC-823 gastric cancer cells]. Cui X, Chen L, Sun J, Wang Y, Lin Z. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb 24; 34(2):129-135. PubMed ID: 29673455 [Abstract] [Full Text] [Related] Page: [Next] [New Search]